LCG
RMD icon

Luxor Capital Group’s ResMed RMD Stock Holding History

Luxor Capital Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-785,271
Closed -$35.1M – 47
2014
Q1 		$35.1M Buy
785,271
+529,999
+208% +$23.8M 0.69% 30
2013
Q4 		$12M Sell
255,272
-2,316,336
-90% -$117M 0.19% 26
2013
Q3 		$136M Sell
2,571,608
-767,714
-23% -$37.2M 1.91% 13
2013
Q2 		$151M Buy
+3,339,322
New +$158M 4.08% 11

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Luxor Capital Group's RMD Position: Q2 2014 in Review

Luxor Capital Group sold out of ResMed (RMD) in Q2 2014, closing a stake of 785,271 shares — an estimated $35.1M sold.

Luxor Capital Group first reported a position in RMD in Q2 2013 and held it in 4 quarters. The position peaked at $151M in Q2 2013. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

  • Luxor Capital Group reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
  • Luxor Capital Group sold 785,271 ResMed shares in Q2 2014, an estimated $35.1M.
  • Luxor Capital Group first reported a position in ResMed in Q2 2013 and held it in 4 quarters.
  • Luxor Capital Group's ResMed position peaked at $151M in Q2 2013.
  • 312 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on Luxor Capital Group's 13F filing for Q2 2014, filed 14 Aug 2014.